Notes - Significant Accounting Policies For Preparation Of Semi-Annual Consolidated Financial Statements
| Concept |
As at 2017-12-31 |
2017-01-01 to 2017-12-31 |
|---|---|---|
| Notes - Significant accounting policies for preparation of semi-annual consolidated financial statements | ||
| Notes - Significant accounting policies for preparation of semi-annual consolidated financial statements | ||
| Disclosure of scope of consolidation | ||
| Number of consolidated subsidiaries and names of major consolidated subsidiaries | — |
(1）連結子会社の状況 連結子会社の数 1社 連結子会社の名称 日本革新創薬株式会社 |
| Number of consolidated subsidiaries |
1
xbrli:pure
|
— |
| Names of major unconsolidated subsidiaries and reasons for exclusion from scope of consolidation | — |
(2）非連結子会社はありません。
|
| Disclosure about fiscal years, etc. of consolidated subsidiaries | — |
２．連結子会社の事業年度等に関する事項 連結子会社の事業年度の末日は、連結決算日と一致しております。 |